Načítá se...
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is one of the most challenging tumors with aggressive behavior, low recovery rate, poor prognosis, high metastatic potential, and rapid relapse compared to other breast cancer subtypes. Conventional therapies currently have minimal effect on TNBC;...
Uloženo v:
| Vydáno v: | Cancers (Basel) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7924562/ https://ncbi.nlm.nih.gov/pubmed/33672756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040898 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|